BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20702005)

  • 1. Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase.
    Maccioni E; Alcaro S; Orallo F; Cardia MC; Distinto S; Costa G; Yanez M; Sanna ML; Vigo S; Meleddu R; Secci D
    Eur J Med Chem; 2010 Oct; 45(10):4490-8. PubMed ID: 20702005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives.
    Sentürk K; Tan OU; Ciftçi SY; Uçar G; Palaska E
    Arch Pharm (Weinheim); 2012 Sep; 345(9):695-702. PubMed ID: 22674756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F
    Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Carradori S; Secci D; Bolasco A; Bizzarri B; Chimenti P; Granese A; Yáñez M; Orallo F
    Eur J Med Chem; 2010 Feb; 45(2):800-4. PubMed ID: 19926363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
    Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
    Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
    Palaska E; Aydin F; Uçar G; Erol D
    Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
    Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
    J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.
    Jagrat M; Behera J; Yabanoglu S; Ercan A; Ucar G; Sinha BN; Sankaran V; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4296-300. PubMed ID: 21680183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Befani O; Turini P; Ortuso F; Alcaro S
    J Med Chem; 2007 Feb; 50(3):425-8. PubMed ID: 17266193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.
    Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Yáñez M; Vitali A; Ortuso F; Alcaro S
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6479-82. PubMed ID: 20934874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
    Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives.
    Chimenti F; Maccioni E; Secci D; Bolasco A; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F; Cirilli R; La Torre F; Cardia MC; Distinto S
    J Med Chem; 2005 Nov; 48(23):7113-22. PubMed ID: 16279769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase B.
    Maccioni E; Alcaro S; Cirilli R; Vigo S; Cardia MC; Sanna ML; Meleddu R; Yanez M; Costa G; Casu L; Matyus P; Distinto S
    J Med Chem; 2011 Sep; 54(18):6394-8. PubMed ID: 21777011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
    Vishnu Nayak B; Ciftci-Yabanoglu S; Jadav SS; Jagrat M; Sinha BN; Ucar G; Jayaprakash V
    Eur J Med Chem; 2013 Nov; 69():762-7. PubMed ID: 24099995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of selective and reversible pyrazoline based MAO-B inhibitors: virtual screening, synthesis and biological evaluation.
    Mishra N; Sasmal D
    Bioorg Med Chem Lett; 2011 Apr; 21(7):1969-73. PubMed ID: 21377879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
    Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
    Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
    Manley-King CI; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.